T Cell-Mediated Tumor Killing-Related Classification of the Immune Microenvironment and Prognosis Prediction of Lung Adenocarcinoma

Background: Although immune checkpoint inhibitors (ICI) are a promising therapeutic strategy for lung adenocarcinoma (LUAD), individual subgroups that might benefit from them are yet to be identified. As T cell-mediated tumor killing (TTK) is an underlying mechanism of ICI, we identified subtypes ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Peng, Liu, Lichao, Bin, Yawen, Huang, Yu, Chen, Lingjuan, Wen, Lu, Zhang, Ruiguang, Tong, Fan, Dong, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739876/
https://www.ncbi.nlm.nih.gov/pubmed/36498802
http://dx.doi.org/10.3390/jcm11237223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739876/
https://www.ncbi.nlm.nih.gov/pubmed/36498802
http://dx.doi.org/10.3390/jcm11237223

Ejemplares similares